RX Propellant Private Limited

RX Propellant Private Limited - life sciences in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U70109TG2020PTC145191 Incorporated 23 October 2020 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company life sciences
Data last updated
Revenue · FY 2025
₹33.2 Cr
▲ 199% YoY
Net loss · FY 2025
₹30.25 Cr
Net margin -91.1%
EBITDA · FY 2025
-₹15.23 Cr
EBITDA margin -45.9%
Authorised capital
₹240.01 Cr
Registered with MCA
Paid-up capital
₹131.01 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
24
Provident fund records
Directors on board
7
As per MCA filings

About RX Propellant Private Limited

Data last updated:

RX Propellant Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Actis Rx 1 (Mauritius) Limited (Formerly Known Actis Treit 16P First (Mauritius) Limited). It operates in the biotechnology segment of the life sciences sector. It was incorporated on 23 October 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U70109TG2020PTC145191. Its GSTIN is 36AAKCR5464J1ZV (Telangana).

The company has an authorised share capital of ₹240.01 Cr and a paid-up capital of ₹131.01 Cr. It was formerly known as Rx Propellant Asset Advisors Private Limited. It is led by directors including Ashish Balram Singh (Managing Director) and Praveen Kumar Poonamallee Sridharan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹33.2 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹30.25 Cr (net margin -91.1%) and EBITDA of -₹15.23 Cr (EBITDA margin -45.9%).

The company has about 24 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Rx Propellant. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹34.01 Cr; the latest was in March 2022.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rxpropellant.com.

Company details

CIN U70109TG2020PTC145191
Registration Number 145191
Incorporation Date 23 October 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Actis Rx 1 (Mauritius) Limited (Formerly Known Actis Treit 16P First (Mauritius) Limited)
Compliance Status Active Compliant

Contact details

RX Propellant Private Limited's registered office is in Hyderabad, Telangana. Its website is rxpropellant.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Unit No 505A 5th Floor Gowra Palladium Plot No 8A And 8B/1, Raidurg Village Serlingampally Mandal Ranga Reddy District, Hyderabad, Telangana, India – 500081
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of RX Propellant Private Limited, buy the company report.

Comprehensive company report
RX Propellant Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

RX Propellant operates one associated brand: Rx Propellant. Each brand links to its own profile.

BrandDescriptionWebsite
Real estate infrastructure development services are provided.rxpropellant.com

Business activity

The main business activity of RX Propellant is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of RX Propellant Private Limited, buy the company report.

Financials of RX Propellant Private Limited

FY 2025 filings available

RX Propellant Private Limited reported revenue of ₹33.2 Cr (up 199% YoY) for FY 2025.

Revenue · FY 2025
₹33.2 Cr ▲ 199%
Net loss · FY 2025
₹30.25 Cr margin -91.1%
EBITDA · FY 2025
-₹15.23 Cr margin -45.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 199%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▼ 765%

Revenue rose 199% in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹15.23 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹30.25 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-45.9%
Net Profit Margin-91.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of RX Propellant Private Limited, buy the company report.

Board of directors and KMP of RX Propellant Private Limited

RX Propellant Private Limited currently reports 6 directors and 1 key managerial person. 5 former directors have served the organization.

Auditor

RX Propellant Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Price Waterhouse Chartered Accountants LLPFY 2023012754N/N500016

Shareholding

The shareholding of RX Propellant Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of RX Propellant Private Limited, buy the company report.

Deals & funding

RX Propellant Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹34.01 Cr; the latest was in March 2022.

Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹34.01 Cr

Deals on record (1 of 3)

WhenDealAmountParties
Mar 2022Funding round₹34.01 CrInvestors: Actis Advisors, RSJS Advisory Services LLP , Clay Business Ventures Private Limited

To see the full deal history of RX Propellant Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for RX Propellant Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

RX Propellant has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
JVRX Asset Management Private LimitedU70109TG2020PTC145003

To see the full group structure of RX Propellant Private Limited, buy the company report.

Employees & EPFO

RX Propellant Private Limited has a workforce of 24 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
24
Active EPFO establishments
1
Employee growth
4.35%

GST

RX Propellant has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAKCR5464J1ZVTelanganaActive05 Jul 2021

To see the full GST registrations and return filing status of RX Propellant Private Limited, buy the company report.

Recent activity

RX Propellant Private Limited has 17 board changes on record since 2020: 12 appointments and 5 cessations. The latest: Ashish Balram Singh was appointed as Managing Director on 22 Oct 2025.

Appointed
Ashish Balram Singh was appointed as Managing Director.
AGM
Rx Propellant Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Jasmeet Singh Chhabra ceased to be Director.
Ceased
Milind Ravi ceased to be CEO.
Ceased
Vishal Goel ceased to be Managing Director.
Filing
Rx Propellant Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Dinesh Meel was appointed as Director.
Appointed
Brian David Chinappi was appointed as Director.
Appointed
Jasmeet Singh Chhabra was appointed as Director.
Appointed
Mohammed Hameeduddin Farouqui was appointed as Company Secretary.
Appointed
Richard Stephen Mully was appointed as Director.
Ceased
Pooja Baheti ceased to be Director.

8 earlier events are in the company report.

Frequently asked questions

RX Propellant is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 23 October 2020 (6+ years old) and is registered under CIN U70109TG2020PTC145191.

RX Propellant has 7 current directors and KMP:

The latest financial statements of RX Propellant on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of RX Propellant is 36AAKCR5464J1ZV, registered in Telangana.

The CIN (Corporate Identification Number) of RX Propellant is U70109TG2020PTC145191. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

RX Propellant was incorporated on 23 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.

RX Propellant has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹34.01 Cr; the latest was in March 2022.

Ashish Balram Singh was appointed as Managing Director on 22 Oct 2025. Jasmeet Singh Chhabra ceased to be Director on 02 May 2025. Milind Ravi ceased to be CEO on 02 May 2025. RX Propellant has 17 board changes on record in total.

RX Propellant can be reached through the website rxpropellant.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of RX Propellant is at Unit No 505A 5th Floor Gowra Palladium Plot No 8A And 8B1, Raidurg Village Serlingampally Mandal Ranga Reddy District, Hyderabad, Telangana, India – 500081.